These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 27817210)
1. Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis. Matar H; Larner J; Viegas V; Kansagra S; Atkinson KL; Shetage S; Skamarauskas JT; Theivendran B; Goldman VS; Chilcott RP Cutan Ocul Toxicol; 2017 Sep; 36(3):211-219. PubMed ID: 27817210 [TBL] [Abstract][Full Text] [Related]
2. Optimisation of a dosing regime for a topical skin protectant (barrier cream). Chilcott RP; Larner J; Matar H; Kansagra S; Theivendran B; Viegas VA; Goldman VS Cutan Ocul Toxicol; 2015; 34(4):327-34. PubMed ID: 25597377 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of topical skin products in the treatment and prevention of incontinence-associated dermatitis: a systematic review. Pather P; Hines S; Kynoch K; Coyer F JBI Database System Rev Implement Rep; 2017 May; 15(5):1473-1496. PubMed ID: 28498177 [TBL] [Abstract][Full Text] [Related]
4. Durability of an Advanced Skin Protectant Compared With Other Commercially Available Products in Healthy Human Volunteers. Muresan M; Muresan S; Brinzaniuc K; Sala D; Neagoe R Wounds; 2018 Sep; 30(9):310-316. PubMed ID: 30256746 [TBL] [Abstract][Full Text] [Related]
5. Effects of a Skin Barrier Cream on Management of Incontinence-Associated Dermatitis in Older Women: A Cluster Randomized Controlled Trial. Kon Y; Ichikawa-Shigeta Y; Iuchi T; Nakajima Y; Nakagami G; Tabata K; Sanada H; Sugama J J Wound Ostomy Continence Nurs; 2017; 44(5):481-486. PubMed ID: 28723852 [TBL] [Abstract][Full Text] [Related]
6. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence: economics of skin damage prevention. Bliss DZ; Zehrer C; Savik K; Smith G; Hedblom E J Wound Ostomy Continence Nurs; 2007; 34(2):143-52; discussion 152. PubMed ID: 17413828 [TBL] [Abstract][Full Text] [Related]
7. Comparing the effectiveness and wash-off resistance of skin barrier creams: a healthy volunteer study. Dykes P; Bradbury S J Wound Care; 2017 Sep; 26(9):552-557. PubMed ID: 28880764 [TBL] [Abstract][Full Text] [Related]
8. Moisture-associated skin damage: use of a skin protectant containing manuka honey. Woodward S Br J Nurs; 2019 Mar; 28(6):329-335. PubMed ID: 30925233 [TBL] [Abstract][Full Text] [Related]
9. A Prospective, Descriptive, Quality Improvement Study to Decrease Incontinence-Associated Dermatitis and Hospital-Acquired Pressure Ulcers. Hall KD; Clark RC Ostomy Wound Manage; 2015 Jul; 61(7):26-30. PubMed ID: 26185973 [TBL] [Abstract][Full Text] [Related]
10. Development of a cumulative irritation model for incontinence-associated dermatitis. Larner J; Matar H; Goldman VS; Chilcott RP Arch Dermatol Res; 2015 Jan; 307(1):39-48. PubMed ID: 25416151 [TBL] [Abstract][Full Text] [Related]
11. Management of incontinence-associated dermatitis patients using a skin protectant in acute care: a case series. Acton C; Ivins N; Bainbridge P; Browning P J Wound Care; 2020 Jan; 29(1):18-26. PubMed ID: 31930942 [TBL] [Abstract][Full Text] [Related]
12. Preventing irritant contact dermatitis with protective creams: influence of the application dose. Schliemann S; Petri M; Elsner P Contact Dermatitis; 2014 Jan; 70(1):19-26. PubMed ID: 23844826 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of a hydrocolloid crusting method versus standard care in the treatment of incontinence-associated dermatitis among adult patients in an acute care setting: A randomised controlled trial. Gunasegaran N; Ang SY; Ng YZ; Lee NES; Agus N; Lee CW; Ong CE; Mostafa SS; Aloweni F J Tissue Viability; 2023 May; 32(2):171-178. PubMed ID: 36717288 [TBL] [Abstract][Full Text] [Related]
14. A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence-associated dermatitis: a randomized, controlled clinical trial. Beeckman D; Verhaeghe S; Defloor T; Schoonhoven L; Vanderwee K J Wound Ostomy Continence Nurs; 2011; 38(6):627-34. PubMed ID: 21952346 [TBL] [Abstract][Full Text] [Related]
15. Does skin care frequency affect the severity of incontinence-associated dermatitis in critically ill patients? Conley P; McKinsey D; Ross O; Ramsey A; Feeback J Nursing; 2014 Dec; 44(12):27-32. PubMed ID: 25406780 [TBL] [Abstract][Full Text] [Related]
16. A Natural Cream-to-Powder Formulation Developed for the Prevention of Diaper Dermatitis in Diaper-Wearing Infants and Children: Barrier Property and In-Use Tolerance Studies. Gunt HB; Levy SB; Lutrario CA J Drugs Dermatol; 2018 May; 17(5):566-570. PubMed ID: 29742190 [TBL] [Abstract][Full Text] [Related]
17. Optimal management of incontinence-associated dermatitis in the elderly. Gray M Am J Clin Dermatol; 2010; 11(3):201-10. PubMed ID: 20131923 [TBL] [Abstract][Full Text] [Related]
18. Time of Onset to Changes in Skin Condition During Exposure to Synthetic Urine: A Prospective Study. Phipps L; Gray M; Call E J Wound Ostomy Continence Nurs; 2019; 46(4):315-320. PubMed ID: 31274862 [TBL] [Abstract][Full Text] [Related]
19. Protecting vulnerable skin from moisture-associated skin damage. Collier M; Simon D Br J Nurs; 2016 Nov; 25(20 Suppl):S26-S32. PubMed ID: 27834525 [TBL] [Abstract][Full Text] [Related]
20. Incontinence-associated dermatitis from a urinary incontinence perspective. Wilson M Br J Nurs; 2018 May; 27(9):S4-S17. PubMed ID: 29749768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]